During the past decade, Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff" are "Type 2 Diabetes Mellitus" (2 trials), "Diabetes Mellitus, Type 2" (1 trials), "Obesity" (1 trials) and "Overweight" (1 trials). Many other conditions were trialed in "Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff" in a lesser frequency.

Most popular intervention types in "Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tirzepatide" (3 trials), "Dulaglutide" (2 trials), "Insulin Glargine" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".